• 한국생물공학회:학술대회논문집
• /
• 한국생물공학회 2003년도 생물공학의 동향(XIII)
• /
• pp.644-647
• /
• 2003

Materials currently used as an injectable bulking agent in the dermatologic and urologic fields revealed several drawbacks such as particles migration, inflammatory reaction, allergic reaction, rapid volume shrinkage, and necessity of a donor site. In this study, we have developed injectable biomaterial comprising poly (DL- lactide-co-glycolide)(PLGA) and hyaluronic acid gel to overcome these problems. PLGA is a biocompatible synthetic material and hyaluronic acid is a common substance found in living organisms. We examined the feasibility of injection through needle and tested biocompatibility in animal model. After transplantation, injected sites and distant organs were examined histologically to verify a new tissue formation, inflammation, and particles migrations. Injected volume was maintained approximately 80 percent for 2 months. Results demonstrated that the developed material was injectable through various gauges of needles and induced a new bulking tissue formation without serious inflammatory reaction.

• 한국복합재료학회:학술대회논문집
• /
• 한국복합재료학회 2001년도 춘계학술발표대회 논문집
• /
• pp.263-267
• /
• 2001

The changes of interfacial properties and microfailure degradation mechanisms of bioabsorbable composites with hydrolysis were investigated using micromechanical test and acoustic emission (AE). As hydrolysis time increased, the tensile strength, the modulus and the elongation of PEA and bioactive glass fibers decreased, whereas those of chitosan fiber changed little. Interfacial shear strength (IFSS) of bioactive glass fiber/poly-L-lactide (PLLA) composite was significantly higher than that two other systems. The decreasing rate of IFSS was the fastest in bioactive glass fiber/PLLA composite, whereas that of chitosan fiber/PLLA composite was the slowest. With increasing hydrolysis time, distribution of AE amplitude was narrow, and AE energy decreased gradually.

• 대한약학회:학술대회논문집
• /
• 대한약학회 2002년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2
• /
• pp.417.2-418
• /
• 2002

The rhGH-loaded PLGA microsphere formulation was prepared using a double emulsion process from hydrophilic 0:50 poly(D.L-lactide-co-glycolide) (PLGA) polymers. To investigate the sustained efficacy of this formulation, ts pharmacodynamic characteristics were analyzed. It showed particle size of ca 53.1 $\mu\textrm{m}$ with high drug ncorporation efficiency and it was sucutaneously administrated to hypophysectomized rats and whole body rowth responses of this formulation were compared to those of the different dosing patterns of rhGH. (omitted)

• Elastomers and Composites
• /
• 제34권4호
• /
• pp.292-298
• /
• 1999

Lactide oligomer with number averagae molecular weight of 460 was synthesized and reacted with poly(oxyteramethylene)glycol(PTMG, Mn = 650) to obtain oligolactide oligomer-terminated PTMG. Polyurethanes were synthesized from the oligolactide-terminated PTMG, 4,4'-diphenylmethane diisocyanate, and 1,4-butanediol. The mechanical and thermal properties of the polyurethanes and PTMG based polyurethane as control were measured by means of DSC and tensile tester. Degradation behavior of these polyurethanes put into a compost was evaluated by variation of mechanical properties, surface state, and weight loss. Modulus and weight significantly decreased with increasing time. The surface of the oligolactide polyurethane put into the compost during 6 weeks had a number of voids. On the other hand, These properties of the PTMG based polyurethane as control did not change. These results suggest that the novel polyurethanes incorporated oligolactide easily degrade under biodegradable condition.

• Journal of Pharmaceutical Investigation
• /
• 제39권5호
• /
• pp.353-357
• /
• 2009

As a synthetic analog of the naturally occurring hormone somatostatin, octreotide has been commercially formulated in poly(lactide-co-glycolide) (PLGA) microspheres for the treatment of acromegaly. The purpose of this study was to evaluate stability of octreotide acetate in aqueous solutions at various pH values and PLGA films. Stability-indicating reversed-phase high-performance liquid chromatographic method was developed with good precision and accuracy, and it was applied to the stability studies. In aqueous solutions at pH 2.5-9.0, the degradation of octreotide followed approximately first order kinetics and the most favorable stability was found at pH 4. In PLGA films, the formation of acylated octreotides reached approximately 55% of the released octreotides. Various acylated octreotides was structurally identified by liquid chromatography-mass spectrometric analysis.

• 대한약학회:학술대회논문집
• /
• 대한약학회 2002년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2
• /
• pp.424.2-424.2
• /
• 2002

The in vivo release characteristics of rhGH-loaded PLGA microsphere prepared using a double emulsion process from hydrophilic 50:50 poly(D.L-lactide-co-glycolide) (PLGA) polymers were analyzed. This formulation showed particle size of ca 53.1$\mu\textrm{m}$ with high drug incorporation efficiency. To investigate in vivo release kinetics without the interference of formation of antibodies to rhGH in the experimental animals, the animals were immunosuppressed by treatment with Cyclosporin. (omitted)

• 대한약학회:학술대회논문집
• /
• 대한약학회 2002년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2
• /
• pp.417.1-417.1
• /
• 2002

The in vitro release of rhGH from PLGA microspheres was characterized. rhGH-loaded PLGA microspheres were prepared with 50:50 poly(D.L-lactide-co-glycolide) (PLGA) polymers using a double emulsion process. To simulate rhGH release under physiological conditions. the microspheres were suspended in a physiological buller at 37$^{\circ}C$. Quantification of the rhGH released and its molecular form analysis were carried out using SE-HPLC. (omitted)

• 폴리머
• /
• 제26권5호
• /
• pp.680-690
• /
• 2002

골 재흡수 치료를 목적으로 파미드로네이트를 지속적으로 방출하는 제형으로 제조하기 위하여 락타이드-글리콜라이드 공중합체 (PLGA, 락타이드 : 글리콜라이드 몰비 = 75 : 25, 분자량 20000 g/mole 및 90000 g/mole)를 이용하여 직접압축 성형방법으로 생분해성 웨이퍼를 제조하였다. 약물과 고분자의 함량비 웨이퍼의 두께, PLGA 분자량 등을 조절하여 PLGA 웨이퍼를 제조하였고 이들의 형태학적 특성과 방출거동 및 분해거동을 살펴보았다. 웨이퍼의 제조는 혼합된 분말을 웨이퍼 제작용 몰드에 넣은 후 프레스를 이용하여 일정 압력으로 일정시간 동안 상온에서 가압하여 제조하였다. 제조된 웨이퍼는 약물의 초기함량이 증가할수록 방출속도가 빠르게 나타났으며, 제형의 두께가 두꺼워질수록 시간이 경과함에 따라 약물의 방출속도가 증가하였다. 또한 고분자의 분자량이 큰 것이 작은 것에 비해 상대적으로 초기 약물 방출량이 적고 방출되는 속도 또한 느려져. 저분자보다 오랫동안 약물이 방출되었다. 이러한 약물전달 시스템은 압축성형방법에 의해 제조하므로 제조가 간단하고 약물방출속도를 정확하게 제어할 수 있으므로 이식을 위한 제형으로 제조시 유용하게 쓰일 것으로 예상되었다.

• 폴리머
• /
• 제33권5호
• /
• pp.458-462
• /
• 2009

본 연구에서는 순차적 음이온 및 개환중합반응을 통해 ABC 형태의 폴리스티렌-폴리에틸렌옥사이드-폴리락티드 블록공중합체를 성공적으로 합성하였다. 우선, 첫번째 블록인 폴리스티렌을 합성하기 위해서, 사이클로헥산 용매에서 스티렌/이차-부틸리튬을 각각 단량체/개시제로 사용하여 음이온중합(anionic polymerization)을 수행하였고, 이후 고분자 말단을 수산기로 전환시키기 위해, 에틸렌옥사이드를 첨가하였다. 다음 단계로 포타슘 나프탈레나이드(potassium naphthalenide)를 이용하여 폴리스티렌 말단 수산기의 수소를 제거하여, 거대개시제인 PS-$O^-K^+$를 제조하였다. 준비된 거대 개시제에 정량된 에틸렌옥사이드를 첨가하여, 음이온중합을 수행하였다. 폴리락티드 블록을 도입시키는 개환중합의 경우, THF 용매에서 트리에틸알루미늄(triethylaluminum)/피리딘(pyridine)시스템을 이용하여 PS-b-PEO-$AlEt_2$ 형태의 거대개시제를 형성한 후, $90^{\circ}C$에서 중합을 수행하였다. 합성된 블록공중합체를 수소핵자기공명법 및 겔침투크로마토그래피 방법을 통해 조사한 결과, 잘 정의된 분자량 및 낮은 분자량 분포를 나타냄을 확인할 수 있었다.

• International Journal of Advanced Culture Technology
• /
• 제3권2호
• /
• pp.100-109
• /
• 2015

Environmental problems from petroleum-based plastic wastes have been rapidly increasing in recent years. The alternative solution is focus on the development of environmental friendly plastic derived from renewable resource. Poly(lactic acid) (PLA) is a biodegradable polymer synthesized from biomass having potential to replace the petroleum-based non-degradable polymers utilizations. PLA can be synthesized by two methods: (1) ring-opening of lactide intermediate and (2) direct polycondensation of lactic acid processes. The latter process has advantages on high yields and high purity of polymer products, materials handling and ease of process treatments. The polymerization process of PLA synthesis has been widely studied in a laboratory scale. However, the mass scale production using direct polycondensation of lactic acid has not been reported. We have investigated the kinetics and scale-up process of direct polycondensation method to produce PLA in a pilot scale. The order of reaction is 2 and activation energy of lactic acid to lactic acid oligomers is 61.58 kJ/mol. The pre-polymer was further polymerized in a solid state polymerization (SSP) process. The synthesized PLA from both the laboratory and pilot scales show the comparable properties such as melting temperature and molecular weight. The appearance of synthesized PLA is yellow-white solid powder.